Found 5 matching trials
This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months PHASE2 The objective of the study is to investigate the efficacy, safety and toler...
Show More Learn More & Join Trial
Safety Tolerability and Pharmacokinetic of BI 409306 PHASE1 The primary objective of the current study is to investigate the safety and...
Show More Location
1289.1.1 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Healthy Volunteers PHASE1 Single site, parallel-group, double-blind trial of low or high dose of BI 4...
Show More Location
University of California San Diego
Learn More & Join Trial
Safety, Tolerability and Pharmacokinetics of BI 409306 Tablets in Healthy Asian Male Volunteers PHASE1 Safety, tolerability and pharmacokinetics of single and multiple oral doses...
Show More Location
1289.4.8201 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 409306 PHASE1 The primary objective of the current study is to investigate the safety and...
Show More Location
1289.17.1 Boehringer Ingelheim Investigational Site
Learn More & Join Trial